Trials / Recruiting
RecruitingNCT02744365
Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Biobank of Data and of Human Biological Samples on Prematurity, Preeclampsia and Other Pregnancy Complications
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,845 (estimated)
- Sponsor
- CHU de Quebec-Universite Laval · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
Detailed description
This Biobank is comprised of: 1) medical, social, obstetrical and ultrasonographic data, 2) human biological samples (maternal plasma, serum and buffy coat, maternal urine, cord blood) and 3) the results derived from these (biochemical or ultrasonographic markers, genetics, risk calculations ...)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational | All women of the biobank have provided: 1. blood samples (plasma, serum and Buffy-coat) 2. urine samples 3. demographic and clinical data (maternal age, BMI, smoking status, obstetrical and medical history) 4. mean arterial blood pressure 5. ultrasound examination (datation of pregnancy at recruitment, uterine arteries doppler, placental volume, nuchal translucency in the majority of the cases) 6. access to medical record (for pregnancy/delivery outcomes, newborn birthweight, gestational age at delivery) |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2025-04-01
- Completion
- 2028-04-01
- First posted
- 2016-04-20
- Last updated
- 2022-03-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02744365. Inclusion in this directory is not an endorsement.